Speaking in the occasion BHU vice-chancellor Professor DP Singh said: “This is a momentous occasion in a year when the university is celebrating the 150th birth anniversary of its founder Pandit Madan Mohan Malaviya”.
He said Pandit Malaviya was a visionary and believed in propagating
He also appreciated BHU’s Faculty of Ayurveda in taking the initiative to have a Public Private Partnership (PPP) which will be the first of its kind.
Under the proposed arrangement Faculty of Ayurveda,
Research will also be focused on medicinal plants used in Ayurveda both in North and
In addition the venture will aim to establish standardization of classical Ayurvedic drugs for purity, safety and efficacy. Large scale and sustainable cultivation of medicinal plants at their habitat form will be a key area of interest.
BHU and KAL will exchange best practices between the Northern Indian and Kerala traditions, in particular “Panchakarma” therapies. The research will aim to validate the fundamental principles of Ayurveda and its therapeutic techniques through modern medical science.
The MoU was signed by Dr. KP Upadhaya, registrar, BHU and Mr Ramesh Vangal , chairman KAL in the presence of the vice-chancellor Professor DP Singh. The meeting was also attended by Gokul Patnaik, Amerish Singh, director of KAL, Prof. Anand Kumar, medical superintendent, Dr Chandramauli Upadhyay and Professor Rajesh Singh, chairman, PPP Cell.
Kerala Ayurveda Limited operates a chain of 30 treatment centers and clinics and three Ayurveda Hospitals located across
KAL has embarked on an exciting journey over the last 2 years to validate Ayurveda through a rigorous, scientific process based on US FDA norms. The research chain has dug deep into the ancient Ayurvedic texts, purity of ingredients, herbal chemistry and validation of claims through science.
Photo: BHU vice-chancellor Professor DP Singh holding meeting with the officials of KAL in Varanasi on February 9, 2011.
Source: PPP Cell-BHU